Latest News
Read the latest news releases and announcements from Par Health.
Par Health Names Dr. William Larkins as EVP and Chief Scientific Officer and President, Sterile Injectables
Par Health Reports Third Quarter 2025 Financial Results and Provides Business Update
Par Health Completes Spin-Off from Mallinckrodt, Creating an Independent Leader in Generic Pharmaceuticals and Sterile Injectables
Investor Information
Media Contact
For questions or comments, reach our Media Relations team here.